Literature DB >> 4106554

Hepatitis-free and stable human serum for intravenous therapy.

W Stephan.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1971        PMID： 4106554     DOI： 10.1111/j.1423-0410.1971.tb01819.x

Source DB:  PubMed          Journal:  Vox Sang        ISSN： 0042-9007            Impact factor:   2.144


× No keyword cloud information.
  8 in total

1.  Simple procedure for the removal of nonspecific inhibitors of rubella virus hemagglutination.

Authors:  R Allen; K Hedlund
Journal:  J Clin Microbiol       Date:  1975-12       Impact factor: 5.948

2.  Inactivation of HIV in plasma derivatives by beta-propiolactone and UV irradiation.

Authors:  H Dichtelmüller; W Stephan; A M Prince; L Gürtler; F Deinhardt
Journal:  Infection       Date:  1987       Impact factor: 3.553

Review 3.  Serology and epidemiology.

Authors:  J H Walsh
Journal:  West J Med       Date:  1975-09

4.  Inhibition of human neutrophil elastase activity by encapsulated serum (Serumsome) therapy.

Authors:  S H Kuhn; M C Finkelstein
Journal:  Appl Biochem Biotechnol       Date:  1984       Impact factor: 2.926

5.  Killing of blood-stage Plasmodium falciparum by lipid peroxides from tumor necrosis serum.

Authors:  K A Rockett; G A Targett; J H Playfair
Journal:  Infect Immun       Date:  1988-12       Impact factor: 3.441

6.  Hepatitis safety of a new prothrombin complex preparation, sterilized according to the method of LoGrippo. Results of a prospective clinical trial.

Authors:  I Hoppe
Journal:  Blut       Date:  1985-06

7.  Rubella serology: a comparison of four methods for exclusion of non-specific serum inhibitors.

Authors:  T Traavik; O Spanne; S Mennen
Journal:  J Hyg (Lond)       Date:  1981-06

8.  Improvement of arbovirus HA antigens by treatment with a colloidal silica gel and sonication.

Authors:  T Traavik
Journal:  Arch Virol       Date:  1977       Impact factor: 2.574
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.